Hubert Kolb

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Anatomy

Disorders

Living Beings

Chemicals & Drugs

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Martin Stephan; Kolb Hubert; Schneider Berthold; Heinemann Lutz; Weber Christian; Kocher Serge; Tshiananga Jacques K T; Scherbaum Werner A; Lodwig Volker
Myocardial infarction and stroke in early years after diagnosis of type 2 diabetes: risk factors and relation to self-monitoring of blood glucose.
Skurk T; Mack I; Kempf K; Kolb H; Hauner H; Herder C
Expression and secretion of RANTES (CCL5) in human adipocytes in response to immunological stimuli and hypoxia.
Martin Stephan; Kolb Hubert
[Non-pharmacological diabetes therapy]

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Hubert Kolb (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Martin Stephan; Kolb Hubert; Schneider Berthold; Heinemann Lutz; Weber Christian; Kocher Serge; Tshiananga Jacques K T; Scherbaum Werner A; Lodwig Volker
Myocardial infarction and stroke in early years after diagnosis of type 2 diabetes: risk factors and relation to self-monitoring of blood glucose.
Diabetes technology & therapeutics 2009;11(4):234-41.
2009: Skurk T; Mack I; Kempf K; Kolb H; Hauner H; Herder C
Expression and secretion of RANTES (CCL5) in human adipocytes in response to immunological stimuli and hypoxia.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2009;41(3):183-9.
2008: Martin Stephan; Kolb Hubert
[Non-pharmacological diabetes therapy]
Medizinische Monatsschrift für Pharmazeuten 2008;31(2):42-51.
2007: Martin S; Schramm W; Schneider B; Neeser K; Weber C; Lodwig V; Heinemann L; Scherbaum W A; Kolb H
Epidemiology of complications and total treatment costs from diagnosis of Type 2 diabetes in Germany (ROSSO 4).
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2007;115(8):495-501.
2007: Schloot N C; Hanifi-Moghaddam P; Aabenhus-Andersen N; Alizadeh B Z; Saha M T; Knip M; Devendra D; Wilkin T; Bonifacio E; Roep B O; Kolb H; Mandrup-Poulsen T
Association of immune mediators at diagnosis of Type 1 diabetes with later clinical remission.
Diabetic medicine : a journal of the British Diabetic Association 2007;24(5):512-20.
2007: Thorand Barbara; Baumert Jens; Kolb Hubert; Meisinger Christa; Chambless Lloyd; Koenig Wolfgang; Herder Christian
Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.
Diabetes care 2007;30(4):854-60.
2007: Kempf K; Rose B; Herder C; Haastert B; Fusbahn-Laufenburg A; Reifferscheid A; Scherbaum W A; Kolb H; Martin S
The metabolic syndrome sensitizes leukocytes for glucose-induced immune gene expression.
Journal of molecular medicine (Berlin, Germany) 2007;85(4):389-96.
2007: Herder C; Hauner H; Kempf K; Kolb H; Skurk T
Constitutive and regulated expression and secretion of interferon-gamma-inducible protein 10 (IP-10/CXCL10) in human adipocytes.
International journal of obesity (2005) 2007;31(3):403-10.
2007: Kolb Hubert; Schneider Berthold; Heinemann Lutz; Lodwig Volker; Martin Stephan
Is self-monitoring of blood glucose appropriate for all type 2 diabetic patients? The Fremantle Diabetes Study.
Diabetes care 2007;30(1):183-4; author reply 184-5.
2006: Herder Christian; Martin Stephan; Kempf Kerstin; Rose Bettina; Kolb Hubert;
The DREAM trial.
Lancet 2006;368(9552):2049; author reply 2050-1.
2006: Kempf Kerstin; Rose Bettina; Herder Christian; Kleophas Ursula; Martin Stephan; Kolb Hubert
Inflammation in metabolic syndrome and type 2 diabetes: Impact of dietary glucose.
Annals of the New York Academy of Sciences 2006;1084():30-48.
2006: Herder Christian; Baumert Jens; Thorand Barbara; Martin Stephan; Löwel Hannelore; Kolb Hubert; Koenig Wolfgang
Chemokines and incident coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(9):2147-52.
2006: Herder Christian; Peltonen Markku; Koenig Wolfgang; Kräft Ilka; Müller-Scholze Sylvia; Martin Stephan; Lakka Timo; Ilanne-Parikka Pirjo; Eriksson Johan G; Hämäläinen Helena; Keinänen-Kiukaanniemi Sirkka; Valle Timo T; Uusitupa Matti; Lindström Jaana; Kolb Hubert; Tuomilehto Jaakko
Systemic immune mediators and lifestyle changes in the prevention of type 2 diabetes: results from the Finnish Diabetes Prevention Study.
Diabetes 2006;55(8):2340-6.
2006: Herder Christian; Hauner Hans; Haastert Burkhard; Röhrig Karin; Koenig Wolfgang; Kolb Hubert; Müller-Scholze Sylvia; Thorand Barbara; Holle Rolf; Rathmann Wolfgang
Hypoadiponectinemia and proinflammatory state: two sides of the same coin?: results from the Cooperative Health Research in the Region of Augsburg Survey 4 (KORA S4).
Diabetes care 2006;29(7):1626-31.
2006: Herder C; Baumert J; Thorand B; Koenig W; de Jager W; Meisinger C; Illig T; Martin S; Kolb H
Chemokines as risk factors for type 2 diabetes: results from the MONICA/KORA Augsburg study, 1984-2002.
Diabetologia 2006;49(5):921-9.
2006: Herder Christian; Müller-Scholze Sylvia; Rating Philipp; Koenig Wolfgang; Thorand Barbara; Haastert Burkhard; Holle Rolf; Illig Thomas; Rathmann Wolfgang; Seissler Jochen; Wichmann H-Erich; Kolb Hubert
Systemic monocyte chemoattractant protein-1 concentrations are independent of type 2 diabetes or parameters of obesity: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4).
European journal of endocrinology / European Federation of Endocrine Societies 2006;154(2):311-7.
2006: Herder Christian; Kolb Hubert; Koenig Wolfgang; Haastert Burkhard; Müller-Scholze Sylvia; Rathmann Wolfgang; Holle Rolf; Thorand Barbara; Wichmann H-Erich
Association of systemic concentrations of macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg, Survey 4 (KORA S4).
Diabetes care 2006;29(2):368-71.
2006: Hanifi-Moghaddam P; Kappler S; Seissler J; Müller-Scholze S; Martin S; Roep B O; Strassburger K; Kolb H; Schloot N C
Altered chemokine levels in individuals at risk of Type 1 diabetes mellitus.
Diabetic medicine : a journal of the British Diabetic Association 2006;23(2):156-63.
2006: Martin S; Schneider B; Heinemann L; Lodwig V; Kurth H-J; Kolb H; Scherbaum W A
Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study.
Diabetologia 2006;49(2):271-8.
2006: Thorand Barbara; Baumert Jens; Chambless Lloyd; Meisinger Christa; Kolb Hubert; Döring Angela; Löwel Hannelore; Koenig Wolfgang;
Elevated markers of endothelial dysfunction predict type 2 diabetes mellitus in middle-aged men and women from the general population.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(2):398-405.
2006: Thorand Barbara; Baumert Jens; Döring Angela; Schneider Andrea; Chambless Lloyd; Löwel Hannelore; Kolb Hubert; Koenig Wolfgang
Association of cardiovascular risk factors with markers of endothelial dysfunction in middle-aged men and women. Results from the MONICA/KORA Augsburg Study.
Thrombosis and haemostasis 2006;95(1):134-41.
2006: Habich Christiane; Kempe Karina; Gomez Francisco J; Lillicrap Mark; Gaston Hill; van der Zee Ruurd; Kolb Hubert; Burkart Volker
Heat shock protein 60: identification of specific epitopes for binding to primary macrophages.
FEBS letters 2006;580(1):115-20.
2006: Rothenbacher Dietrich; Müller-Scholze Sylvia; Herder Christian; Koenig Wolfgang; Kolb Hubert
Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(1):194-9.
2006: Thorand Barbara; Baumert Jens; Döring Angela; Herder Christian; Kolb Hubert; Rathmann Wolfgang; Giani Guido; Koenig Wolfgang;
Sex differences in the relation of body composition to markers of inflammation.
Atherosclerosis 2006;184(1):216-24.
2005: Herder Christian; Haastert Burkhard; Müller-Scholze Sylvia; Koenig Wolfgang; Thorand Barbara; Holle Rolf; Wichmann H-Erich; Scherbaum Werner A; Martin Stephan; Kolb Hubert
Association of systemic chemokine concentrations with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4).
Diabetes 2005;54 Suppl 2():S11-7.
2005: Thorand Barbara; Kolb Hubert; Baumert Jens; Koenig Wolfgang; Chambless Lloyd; Meisinger Christa; Illig Thomas; Martin Stephan; Herder Christian
Elevated levels of interleukin-18 predict the development of type 2 diabetes: results from the MONICA/KORA Augsburg Study, 1984-2002.
Diabetes 2005;54(10):2932-8.
2005: Illig T; Bongardt F; Schöpfer-Wendels A; Huth C; Heid I; Rathmann W; Martin S; Vollmert C; Holle R; Thorand B; Wichmann H E; Koenig W; Kolb H; Herder C;
Genetics of type 2 diabetes: impact of interleukin-6 gene variants.
Gesundheitswesen (Bundesverband der Ärzte des Öffentlichen Gesundheitsdienstes (Germany)) 2005;67 Suppl 1():S122-6.
2005: Herder C; Illig T; Rathmann W; Martin S; Haastert B; Müller-Scholze S; Holle R; Thorand B; Koenig W; Wichmann H E; Kolb H;
Inflammation and type 2 diabetes: results from KORA Augsburg.
Gesundheitswesen (Bundesverband der Ärzte des Öffentlichen Gesundheitsdienstes (Germany)) 2005;67 Suppl 1():S115-21.
2005: Skurk Thomas; Kolb Hubert; Müller-Scholze Sylvia; Röhrig Karin; Hauner Hans; Herder Christian
The proatherogenic cytokine interleukin-18 is secreted by human adipocytes.
European journal of endocrinology / European Federation of Endocrine Societies 2005;152(6):863-8.
2005: Mostafazadeh A; Herder C; Haastert B; Hanifi-Moghaddam P; Schloot N; Koenig W; Illig T; Thorand B; Holle R; Eslami M-B; Kolb H;
Association of humoral immunity to human Hsp60 with the IL-6 gene polymorphism C-174G in patients with type 2 diabetes and controls.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2005;37(4):257-63.
2005: Skurk Thomas; Herder Christian; Kräft Ilka; Müller-Scholze Sylvia; Hauner Hans; Kolb Hubert
Production and release of macrophage migration inhibitory factor from human adipocytes.
Endocrinology 2005;146(3):1006-11.
2005: Habich Christiane; Kempe Karina; van der Zee Ruurd; Rümenapf Robert; Akiyama Hidehiko; Kolb Hubert; Burkart Volker
Heat shock protein 60: specific binding of lipopolysaccharide.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(3):1298-305.
2004: Illig T; Bongardt F; Schöpfer A; Müller-Scholze S; Rathmann W; Koenig W; Thorand B; Vollmert C; Holle R; Kolb H; Herder C;
Significant association of the interleukin-6 gene polymorphisms C-174G and A-598G with type 2 diabetes.
The Journal of clinical endocrinology and metabolism 2004;89(10):5053-8.
2004: Füth Reiner; Herder Christian; Förster Stefan; Müller-Scholze Sylvia; Kruse Niels; Rieckmann Peter; Heinig Antonia; Koenig Wolfgang; Scherbaum Werner A; Kolb Hubert; Martin Stephan
Evaluation of diagnostic relevance of mRNA levels in peripheral blood: predictive value for mortality in hemodialysis patients.
Cytokine 2004;27(6):166-72.
2004: Nikulina Marina; Habich Christiane; Flohé Stefanie B; Scott Fraser W; Kolb Hubert
Wheat gluten causes dendritic cell maturation and chemokine secretion.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(3):1925-33.
2004: Hansner T; Kauer M; Gornitzka G; Kolb H; Martin S
Identification of pancreatic exocrinopathy in non-obese diabetic mice by gene subtraction analysis.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2004;112(6):288-93.
2004: Habich Christiane; Kempe Karina; Burkart Volker; Van Der Zee Ruurd; Lillicrap Mark; Gaston Hill; Kolb Hubert
Identification of the heat shock protein 60 epitope involved in receptor binding on macrophages.
FEBS letters 2004;568(1-3):65-9.
2004: Rose Bettina; Herder Christian; Löffler Heike; Kolb Hubert; Martin Stephan
Combined activation of innate and T cell immunity for recognizing immunomodulatory properties of therapeutic agents.
Journal of leukocyte biology 2004;75(4):624-30.
2003: Martin S; Kolb H; Beuth J; van Leendert R; Schneider B; Scherbaum W A
Change in patients' body weight after 12 months of treatment with glimepiride or glibenclamide in Type 2 diabetes: a multicentre retrospective cohort study.
Diabetologia 2003;46(12):1611-7.
2003: Illig Thomas; Bongardt Friedhelm; Schöpfer Andreas; Holle Rolf; Müller Sylvia; Rathmann Wolfgang; Koenig Wolfgang; Meisinger Christa; Wichmann H-Erich; Kolb Hubert;
The endotoxin receptor TLR4 polymorphism is not associated with diabetes or components of the metabolic syndrome.
Diabetes 2003;52(11):2861-4.
2003: Stumpo Rita; Kauer Manfred; Martin Stephan; Kolb Hubert
IL-10 induces gene expression in macrophages: partial overlap with IL-5 but not with IL-4 induced genes.
Cytokine 2003;24(1-2):46-56.
2003: Martin S; Reipen M; van Leendert R; Beuth J; Kolb H; Scherbaum W A
[Pilot study of controlled retrospective analysis (retrolective study design) of care for type 2 diabetics since 1990]
Deutsche medizinische Wochenschrift (1946) 2003;128(21):1173-8.
2003: Hanifi-Moghaddam Pejman; Schloot Nanette C; Kappler Simone; Seissler Jochen; Kolb Hubert
An association of autoantibody status and serum cytokine levels in type 1 diabetes.
Diabetes 2003;52(5):1137-42.
2003: Flohé Stefanie B; Brüggemann Jutta; Lendemans Sven; Nikulina Marina; Meierhoff Guido; Flohé Sascha; Kolb Hubert
Human heat shock protein 60 induces maturation of dendritic cells versus a Th1-promoting phenotype.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(5):2340-8.
2003: Flohé S B; Wasmuth H E; Kerad J B; Beales P E; Pozzilli P; Elliott R B; Hill J P; Scott F W; Kolb H
A wheat-based, diabetes-promoting diet induces a Th1-type cytokine bias in the gut of NOD mice.
Cytokine 2003;21(3):149-54.
2003: Thorand Barbara; Löwel Hannelore; Schneider Andrea; Kolb Hubert; Meisinger Christa; Fröhlich Margit; Koenig Wolfgang
C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998.
Archives of internal medicine 2003;163(1):93-9.
2003: Habich Christiane; Kempe Karina; van der Zee Ruurd; Burkart Volker; Kolb Hubert
Different heat shock protein 60 species share pro-inflammatory activity but not binding sites on macrophages.
FEBS letters 2003;533(1-3):105-9.
2002: Walz M; Overbergh L; Mathieu C; Kolb H; Martin S
A murine interleukin-4-Ig fusion protein regulates the expression of Th1- and Th2-specific cytokines in the pancreas of NOD mice.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2002;34(10):561-9.
2002: Beales P E; Elliott R B; Flohé S; Hill J P; Kolb H; Pozzilli P; Wang G-S; Wasmuth H; Scott F W
A multi-centre, blinded international trial of the effect of A(1) and A(2) beta-casein variants on diabetes incidence in two rodent models of spontaneous Type I diabetes.
Diabetologia 2002;45(9):1240-6.
2002: Müller S; Martin S; Koenig W; Hanifi-Moghaddam P; Rathmann W; Haastert B; Giani G; Illig T; Thorand B; Kolb H
Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors.
Diabetologia 2002;45(6):805-12.
2002: Adler Thure; Akiyama Hidehiko; Herder Christian; Kolb Hubert; Burkart Volker
Heat shock protein 60 elicits abnormal response in macrophages of diabetes-prone non-obese diabetic mice.
Biochemical and biophysical research communications 2002;294(3):592-6.
2002: Flohé Stefanie B; Brüggemann Jutta; Herder Christian; Goebel Carsten; Kolb Hubert
Enhanced proinflammatory response to endotoxin after priming of macrophages with lead ions.
Journal of leukocyte biology 2002;71(3):417-24.
2002: Burkart Volker; Kim Yoong-Eun; Hartmann Bettina; Ghiea Iona; Syldath Ulrike; Kauer Manfred; Fingberg Waltraud; Hanifi-Moghaddam Pejman; Müller Sylvia; Kolb Hubert
Cholera toxin B pretreatment of macrophages and monocytes diminishes their proinflammatory responsiveness to lipopolysaccharide.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(4):1730-7.
2002: Schloot N C; Hanifi-Moghaddam P; Goebel C; Shatavi S V; Flohé S; Kolb H; Rothe H
Serum IFN-gamma and IL-10 levels are associated with disease progression in non-obese diabetic mice.
Diabetes/metabolism research and reviews 2002;18(1):64-70.
2002: Rothe H; Hausmann A; Kolb H
Immunoregulation during disease progression in prediabetic NOD mice: inverse expression of arginase and prostaglandin H synthase 2 vs. interleukin-15.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2002;34(1):7-12.
2002: Habich Christiane; Baumgart Karina; Kolb Hubert; Burkart Volker
The receptor for heat shock protein 60 on macrophages is saturable, specific, and distinct from receptors for other heat shock proteins.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(2):569-76.
2002: Scott Fraser W; Rowsell Paul; Wang Gen-Sheng; Burghardt Karolina; Kolb Hubert; Flohé Stefanie
Oral exposure to diabetes-promoting food or immunomodulators in neonates alters gut cytokines and diabetes.
Diabetes 2002;51(1):73-8.
2001: Kolb H; Gale E A
Does partial preservation of residual beta-cell function justify immune intervention in recent onset Type I diabetes?
Diabetologia 2001;44(10):1349-53.
2001: Martin S; van den Engel N K; Vinke A; Heidenthal E; Schulte B; Kolb H
Dominant role of intercellular adhesion molecule-1 in the pathogenesis of autoimmune diabetes in non-obese diabetic mice.
Journal of autoimmunity 2001;17(2):109-17.
2000: Wasmuth H E; Kolb H
Cow's milk and immune-mediated diabetes.
The Proceedings of the Nutrition Society 2000;59(4):573-9.
2000: Goebel C; Flohé S B; Kirchhoff K; Herder C; Kolb H
Orally administered lead chloride induces bias of mucosal immunity.
Cytokine 2000;12(9):1414-8.
2000: Bellmann K; Burkart V; Bruckhoff J; Kolb H; Landry J
p38-dependent enhancement of cytokine-induced nitric-oxide synthase gene expression by heat shock protein 70.
The Journal of biological chemistry 2000;275(24):18172-9.
2000: Burkart V; Liu H; Bellmann K; Wissing D; Jäättela M; Cavallo M G; Pozzilli P; Briviba K; Kolb H
Natural resistance of human beta cells toward nitric oxide is mediated by heat shock protein 70.
The Journal of biological chemistry 2000;275(26):19521-8.
2000: Wasmuth H E; Hess G; Viergutz C; Henrichs H R; Martin S; Kolb H
Non-specific viral infections as possible synchronising events of the manifestation of type 1 diabetes.
Diabetes/metabolism research and reviews 2000;16(3):177-8.
2000: van Den Engel N K; Heidenthal E; Vinke A; Kolb H; Martin S
Circulating forms of intercellular adhesion molecule (ICAM)-1 in mice lacking membranous ICAM-1.
Blood 2000;95(4):1350-5.
2000: Ohashi K; Burkart V; Flohé S; Kolb H
Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(2):558-61.
1999: Burkart V; Blaeser K; Kolb H
Potent beta-cell protection in vitro by an isoquinolinone-derived PARP inhibitor.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1999;31(12):641-4.
1999: Kallmann B A; Lampeter E F; Hanifi-Moghaddam P; Hawa M; Leslie R D; Kolb H
Cytokine secretion patterns in twins discordant for Type I diabetes.
Diabetologia 1999;42(9):1080-5.
1999: Rothe H; Hausmann A; Casteels K; Okamura H; Kurimoto M; Burkart V; Mathieu C; Kolb H
IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(3):1230-6.
1999: Kolb H; Pozzilli P
Cow's milk and type I diabetes: the gut immune system deserves attention.
Immunology today 1999;20(3):108-10.
1999: Kolb H; Burkart V
Nicotinamide in type 1 diabetes. Mechanism of action revisited.
Diabetes care 1999;22 Suppl 2():B16-20.
1999: Chen W; Syldath U; Bellmann K; Burkart V; Kolb H
Human 60-kDa heat-shock protein: a danger signal to the innate immune system.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(6):3212-9.
1999: Burkart V; Wang Z Q; Radons J; Heller B; Herceg Z; Stingl L; Wagner E F; Kolb H
Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin.
Nature medicine 1999;5(3):314-9.
1999: Eckhardt W; Bellmann K; Kolb H
Regulation of inducible nitric oxide synthase expression in beta cells by environmental factors: heavy metals.
The Biochemical journal 1999;338 ( Pt 3)():695-700.
1999: Rothe H; Kolb H
Strategies of protection from nitric oxide toxicity in islet inflammation.
Journal of molecular medicine (Berlin, Germany) 1999;77(1):40-4.
1999: Burkart V; Kim Y; Kauer M; Kolb H
Induction of tolerance in macrophages by cholera toxin B chain.
Pathobiology : journal of immunopathology, molecular and cellular biology 1999;67(5-6):314-7.
1999: Stumpo R; Kauer M; Martin S; Kolb H
Alternative activation of macrophage by IL-10.
Pathobiology : journal of immunopathology, molecular and cellular biology 1999;67(5-6):245-8.
1999: Kallmann B A; Malzkorn R; Kolb H
Exogenous nitric oxide modulates cytokine production in human leukocytes.
Life sciences 1999;65(17):1787-94.
1999: Kolb H
Pathophysiology of type 1 diabetes mellitus.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 1999;107 Suppl 3():S88.
1999: Goebel C; Kirchhoff K; Wasmuth H; Flohé S; Elliott R B; Kolb H
The gut cytokine balance as a target of lead toxicity.
Life sciences 1999;64(24):2207-14.
1998: Martin S; Heidenthal E; Schulte B; Rothe H; Kolb H
Soluble forms of intercellular adhesion molecule-1 inhibit insulitis and onset of autoimmune diabetes.
Diabetologia 1998;41(11):1298-303.
1998: Bellmann K; Kolb H; Rastegar S; Jee P; Scott F W
Potential risk of oral insulin with adjuvant for the prevention of Type I diabetes: a protocol effective in NOD mice may exacerbate disease in BB rats.
Diabetologia 1998;41(7):844-7.
1998: Lampeter E F; Klinghammer A; Scherbaum W A; Heinze E; Haastert B; Giani G; Kolb H
The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group.
Diabetes 1998;47(6):980-4.
1998: Kleemann R; Scott F W; Wörz-Pagenstert U; Nimal Ratnayake W M; Kolb H
Impact of dietary fat on Th1/Th2 cytokine gene expression in the pancreas and gut of diabetes-prone BB rats.
Journal of autoimmunity 1998;11(1):97-103.
1998: Rothe H; Kolb H
The APC1 concept of type I diabetes.
Autoimmunity 1998;27(3):179-84.
1997: Bellmann K; Kolb H; Hartmann B; Rothe H; Rowsell P; Rastegar S; Burghardt K; Scott F W
Intervention in autoimmune diabetes by targeting the gut immune system.
International journal of immunopharmacology 1997;19(9-10):573-7.
1997: Hartmann B; Bellmann K; Ghiea I; Kleemann R; Kolb H
Oral insulin for diabetes prevention in NOD mice: potentiation by enhancing Th2 cytokine expression in the gut through bacterial adjuvant.
Diabetologia 1997;40(8):902-9.
1997: Rothe H; O'Hara R M; Martin S; Kolb H
Suppression of cyclophosphamide induced diabetes development and pancreatic Th1 reactivity in NOD mice treated with the interleukin (IL)-12 antagonist IL-12(p40)2.
Diabetologia 1997;40(6):641-6.
1997: Rothe H; Hibino T; Itoh Y; Kolb H; Martin S
Systemic production of interferon-gamma inducing factor (IGIF) versus local IFN-gamma expression involved in the development of Th1 insulitis in NOD mice.
Journal of autoimmunity 1997;10(3):251-6.
1997: Scott F W; Cloutier H E; Kleemann R; Wöerz-Pagenstert U; Rowsell P; Modler H W; Kolb H
Potential mechanisms by which certain foods promote or inhibit the development of spontaneous diabetes in BB rats: dose, timing, early effect on islet area, and switch in infiltrate from Th1 to Th2 cells.
Diabetes 1997;46(4):589-98.
1997: Radons J; Burkart V; Kolb H
MHC class II-dependent abnormal reactivity toward bacterial superantigens in immune cells of NOD mice.
Diabetes 1997;46(3):379-85.
1997: Rothe H; Jenkins N A; Copeland N G; Kolb H
Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near Idd2.
The Journal of clinical investigation 1997;99(3):469-74.
1997: Kallmann B A; Hüther M; Tubes M; Feldkamp J; Bertrams J; Gries F A; Lampeter E F; Kolb H
Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves' disease.
Diabetes 1997;46(2):237-43.
1997: Bellmann K; Hui L; Radons J; Burkart V; Kolb H
Low stress response enhances vulnerability of islet cells in diabetes-prone BB rats.
Diabetes 1997;46(2):232-6.
1997: Kolb H; Wörz-Pagenstert U; Kleemann R; Rothe H; Rowsell P; Rastegar S; Scott F W
Insulin therapy of prediabetes suppresses TH1 associated gene expression in BB rat pancreas.
Autoimmunity 1997;26(1):1-6.
1997: Heller B; Bürkle A; Radons J; Fengler E; Müller M; Burkart V; Kolb H
DNA-damage and NAD(+)-depletion are initial events in oxygen radical induced islet cell death.
Advances in experimental medicine and biology 1997;426():329-34.
1997: Heller B; Burkart V; Lampeter E; Kolb H
Antioxidant therapy for the prevention of type I diabetes.
Advances in pharmacology (San Diego, Calif.) 1997;38():629-38.
1996: Martin S; Kolb H; Lampeter E F
[Current therapeutic strategy in type 1 diabetes and its preclinical stages]
Der Internist 1996;37(12):1289-304.
1996: Kolb H; Wörz-Pagenstert U; Kleemann R; Rothe H; Rowsell P; Scott F W
Cytokine gene expression in the BB rat pancreas: natural course and impact of bacterial vaccines.
Diabetologia 1996;39(12):1448-54.
1996: Burkart V; Brenner H H; Hartmann B; Kolb H
Metabolic activation of islet cells improves resistance against oxygen radicals or streptozocin, but not nitric oxide.
The Journal of clinical endocrinology and metabolism 1996;81(11):3966-71.
1996: Rothe H; Burkart V; Faust A; Kolb H
Interleukin-12 gene expression mediates the accelerating effect of cyclophosphamide in autoimmune disease.
Annals of the New York Academy of Sciences 1996;795():397-9.
1996: Martin S; Hibino T; Faust A; Kleemann R; Kolb H
Differential expression of ICAM-1 and LFA-1 versus L-selectin and VCAM-1 in autoimmune insulitis of NOD mice and association with both Th1- and Th2-type infiltrates.
Journal of autoimmunity 1996;9(5):637-43.
1996: Burkart V; Kolb H
Macrophages in islet destruction in autoimmune diabetes mellitus.
Immunobiology 1996;195(4-5):601-13.
1996: Faust A; Rothe H; Schade U; Lampeter E; Kolb H
Primary nonfunction of islet grafts in autoimmune diabetic nonobese diabetic mice is prevented by treatment with interleukin-4 and interleukin-10.
Transplantation 1996;62(5):648-52.
1996: Bellmann K; Jäättelä M; Wissing D; Burkart V; Kolb H
Heat shock protein hsp70 overexpression confers resistance against nitric oxide.
FEBS letters 1996;391(1-2):185-8.
1996: Rothe H; Hartmann B; Geerlings P; Kolb H
Interleukin-12 gene-expression of macrophages is regulated by nitric oxide.
Biochemical and biophysical research communications 1996;224(1):159-63.
1996: Rothe H; Bosse G; Fischer H G; Kolb H
Generation and characterization of inducible nitric oxide synthase deficient macrophage cell lines.
Biological chemistry Hoppe-Seyler 1996;377(4):227-31.
1996: Rothe H; Burkart V; Faust A; Kolb H
Interleukin-12 gene expression is associated with rapid development of diabetes mellitus in non-obese diabetic mice.
Diabetologia 1996;39(1):119-22.
1995: Lampeter E F; Tubes M; Klemens C; Brocker U; Friemann J; Kolb-Bachofen V; Gries F A; Kolb H
Insulitis and islet-cell antibody formation in rats with experimentally reduced beta-cell mass.
Diabetologia 1995;38(12):1397-404.
1995: Bellmann K; Wenz A; Radons J; Burkart V; Kleemann R; Kolb H
Heat shock induces resistance in rat pancreatic islet cells against nitric oxide, oxygen radicals and streptozotocin toxicity in vitro.
The Journal of clinical investigation 1995;95(6):2840-5.
1995: Burkart V; Gross-Eick A; Bellmann K; Radons J; Kolb H
Suppression of nitric oxide toxicity in islet cells by alpha-tocopherol.
FEBS letters 1995;364(3):259-63.
1995: Heller B; Wang Z Q; Wagner E F; Radons J; Bürkle A; Fehsel K; Burkart V; Kolb H
Inactivation of the poly(ADP-ribose) polymerase gene affects oxygen radical and nitric oxide toxicity in islet cells.
The Journal of biological chemistry 1995;270(19):11176-80.
1995: Kolb H; Kolb-Bachofen V; Roep B O
Autoimmune versus inflammatory type I diabetes: a controversy?
Immunology today 1995;16(4):170-2.
1995: Lampeter E F; Gurniak M; Brocker U; Klemens C; Tubes M; Friemann J; Kolb H
Regeneration of beta-cells in response to islet inflammation.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 1995;103 Suppl 2():74-8.
1994: Rothe H; Faust A; Schade U; Kleemann R; Bosse G; Hibino T; Martin S; Kolb H
Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not of interleukin-4.
Diabetologia 1994;37(11):1154-8.
1994: Burkart V; Bellmann K; Hartmann B; Heller B; Imai Y; Kolb H
Fusidic acid suppresses nitric oxide toxicity in pancreatic islet cells.
Biochemical pharmacology 1994;48(7):1379-85.
1994: Heller B; Bürkle A; Radons J; Fengler E; Jalowy A; Müller M; Burkart V; Kolb H
Analysis of oxygen radical toxicity in pancreatic islets at the single cell level.
Biological chemistry Hoppe-Seyler 1994;375(9):597-602.
1994: Roep B O; Heidenthal E; de Vries R R; Kolb H; Martin S
Soluble forms of intercellular adhesion molecule-1 in insulin-dependent diabetes mellitus.
Lancet 1994;343(8913):1590-3.
1994: Lampeter E F; Seifert I; Lohmann D; Heise J W; Bertrams J; Christie M R; Kolb-Bachofen V; Kolb H
Inflammatory islet damage in patients bearing HLA-DR 3 and/or DR 4 haplotypes does not lead to islet autoimmunity.
Diabetologia 1994;37(5):471-5.
1994: Rothe H; Ongören C; Martin S; Rösen P; Kolb H
Abnormal TNF-alpha production in diabetes-prone BB rats: enhanced TNF-alpha expression and defective PGE2 feedback inhibition.
Immunology 1994;81(3):407-13.
1994: Radons J; Heller B; Bürkle A; Hartmann B; Rodriguez M L; Kröncke K D; Burkart V; Kolb H
Nitric oxide toxicity in islet cells involves poly(ADP-ribose) polymerase activation and concomitant NAD+ depletion.
Biochemical and biophysical research communications 1994;199(3):1270-7.
1994: Böhmer K P; Kolb H; Kuglin B; Zielasek J; Hübinger A; Lampeter E F; Weber B; Kolb-Bachofen V; Jastram H U; Bertrams J
Linear loss of insulin secretory capacity during the last six months preceding IDDM. No effect of antiedematous therapy with ketotifen.
Diabetes care 1994;17(2):138-41.
1994: Hartmann B; Ngezahayo A; Heller B; Jalowy A; Burkart V; Kolb H A; Kolb H
Nitric oxide toxicity in pancreatic islet cells: role of protein biosynthesis, calcium influx and arachidonic acid metabolism.
Biochemical Society transactions 1994;22(1):23-6.
1994: Faust A; Burkart V; Ulrich H; Weischer C H; Kolb H
Effect of lipoic acid on cyclophosphamide-induced diabetes and insulitis in non-obese diabetic mice.
International journal of immunopharmacology 1994;16(1):61-6.
1994: Kolb H
Immune intervention in type I diabetes mellitus--current clinical and experimental approaches.
Experimental and clinical endocrinology 1994;102(4):269-72.
1993: Imai Y; Kolb H; Burkart V
Nitric oxide production from macrophages is regulated by arachidonic acid metabolites.
Biochemical and biophysical research communications 1993;197(1):105-9.
1993: Rothe H; Ongören C; Rösen P; Kolb H
Genetic analysis of aberrant tumor necrosis factor alpha production in prediabetic BB-rats.
Transplantation proceedings 1993;25(5):2833-4.
1993: Kröncke K D; Brenner H H; Rodriguez M L; Etzkorn K; Noack E A; Kolb H; Kolb-Bachofen V
Pancreatic islet cells are highly susceptible towards the cytotoxic effects of chemically generated nitric oxide.
Biochimica et biophysica acta 1993;1182(2):221-9.
1993: Burkart V; Kolb H
Protection of islet cells from inflammatory cell death in vitro.
Clinical and experimental immunology 1993;93(2):273-8.
1993: Berschick P; Fehsel K; Weltzien H U; Kolb H
Molecular analysis of the T-cell receptor V beta 5 and V beta 8 repertoire in pancreatic lesions of autoimmune diabetic NOD mice.
Journal of autoimmunity 1993;6(4):405-22.
1993: Kleemann R; Rothe H; Kolb-Bachofen V; Xie Q W; Nathan C; Martin S; Kolb H
Transcription and translation of inducible nitric oxide synthase in the pancreas of prediabetic BB rats.
FEBS letters 1993;328(1-2):9-12.
1993: Koike T; Fehsel K; Zielasek J; Kolb H; Burkart V
Gangliosides protect from TNF alpha-induced apoptosis.
Immunology letters 1993;35(3):207-12.
1993: Fehsel K; Jalowy A; Qi S; Burkart V; Hartmann B; Kolb H
Islet cell DNA is a target of inflammatory attack by nitric oxide.
Diabetes 1993;42(3):496-500.
1993: Burkart V; Koike T; Brenner H H; Imai Y; Kolb H
Dihydrolipoic acid protects pancreatic islet cells from inflammatory attack.
Agents and actions 1993;38(1-2):60-5.
1993: Kröncke K D; Rodriguez M L; Kolb H; Kolb-Bachofen V
Cytotoxicity of activated rat macrophages against syngeneic islet cells is arginine-dependent, correlates with citrulline and nitrite concentrations and is identical to lysis by the nitric oxide donor nitroprusside.
Diabetologia 1993;36(1):17-24.
1993: Brenner H H; Burkart V; Rothe H; Kolb H
Oxygen radical production is increased in macrophages from diabetes prone BB rats.
Autoimmunity 1993;15(2):93-8.
1992: Lampeter E R; Kishimoto T K; Rothlein R; Mainolfi E A; Bertrams J; Kolb H; Martin S
Elevated levels of circulating adhesion molecules in IDDM patients and in subjects at risk for IDDM.
Diabetes 1992;41(12):1668-71.
1992: Burkart V; Koike T; Brenner H H; Kolb H
Oxygen radicals generated by the enzyme xanthine oxidase lyse rat pancreatic islet cells in vitro.
Diabetologia 1992;35(11):1028-34.
1992: Burkart V; Imai Y; Kallmann B; Kolb H
Cyclosporin A protects pancreatic islet cells from nitric oxide-dependent macrophage cytotoxicity.
FEBS letters 1992;313(1):56-8.
1992: Rothe H; Schuller I; Richter G; Jongeneel C V; Kiesel U; Diamantstein T; Blankenstein T; Kolb H
Abnormal TNF production in prediabetic BB rats is linked to defective CD45R expression.
Immunology 1992;77(1):1-6.
1992: Burkart V; Zielasek J; Kantwerk-Funke G; Hibbe T; Schwab E; Kolb H
Low dose streptozotocin-induced diabetes in mice: reduced IL-2 production and modulation of streptozotocin-induced hyperglycemia by IL-2.
International journal of immunopharmacology 1992;14(6):1037-44.
1992: Kolb H; Kolb-Bachofen V
Type 1 (insulin-dependent) diabetes mellitus and nitric oxide.
Diabetologia 1992;35(8):796-7.
1992: Kolb H; Kolb-Bachofen V
Nitric oxide: a pathogenetic factor in autoimmunity.
Immunology today 1992;13(5):157-60.
1992: Bergmann L; Kröncke K D; Suschek C; Kolb H; Kolb-Bachofern V
Cytotoxic action of IL-1 beta against pancreatic islets is mediated via nitric oxide formation and is inhibited by NG-monomethyl-L-arginine.
FEBS letters 1992;299(1):103-6.
1992: Zielasek J; Kolb H
Ganglioside therapy of type I diabetes: enhancement of hyperglycemia in the low dose streptozotocin model.
Life sciences 1992;51(1):49-52.
1992: Kolb-Bachofen V; Schraermeyer U; Hoppe T; Hanenberg H; Kolb H
Diabetes manifestation in BB rats is preceded by pan-pancreatic presence of activated inflammatory macrophages.
Pancreas 1992;7(5):578-84.
1992: Kallmann B; Burkart V; Kröncke K D; Kolb-Bachofen V; Kolb H
Toxicity of chemically generated nitric oxide towards pancreatic islet cells can be prevented by nicotinamide.
Life sciences 1992;51(9):671-8.
1991: Böhmer K; Keilacker H; Kuglin B; Hübinger A; Bertrams J; Gries F A; Kolb H
Proinsulin autoantibodies are more closely associated with type 1 (insulin-dependent) diabetes mellitus than insulin autoantibodies.
Diabetologia 1991;34(11):830-4.
1991: Kantwerk-Funke G; Burkart V; Kolb H
Low dose streptozotocin causes stimulation of the immune system and of anti-islet cytotoxicity in mice.
Clinical and experimental immunology 1991;86(2):266-70.
1991: Martin S; Rothe H; Tschöpe D; Schwippert B; Kolb H
Decreased expression of adhesion molecules on monocytes in recent onset IDDM.
Immunology 1991;73(1):123-5.
1991: Kröncke K D; Funda J; Berschick B; Kolb H; Kolb-Bachofen V
Macrophage cytotoxicity towards isolated rat islet cells: neither lysis nor its protection by nicotinamide are beta-cell specific.
Diabetologia 1991;34(4):232-8.
1991: Kröncke K D; Kolb-Bachofen V; Berschick B; Burkart V; Kolb H
Activated macrophages kill pancreatic syngeneic islet cells via arginine-dependent nitric oxide generation.
Biochemical and biophysical research communications 1991;175(3):752-8.
1991: Huber H; Berschick P; Kolb H
Analysis of IL-2 receptor positive CD8(+)-T-lymphocytes grown from islets of NOD mice.
Diabetes research (Edinburgh, Scotland) 1991;16(2):69-73.
1991: Hibbe T; Kiesel U; Kolb-Bachofen V; Kolb H
Methimazole treatment aggravates low-dose streptozotocin-induced diabetes.
Diabetes research and clinical practice 1991;11(1):53-8.
1990: Kuglin B; Halder B; Bertrams J; Grüneklee D; Gries F A; Kolb H
Proinsulin autoantibodies: association with type I diabetes but not with islet cell antibodies, insulin autoantibodies or HLA-DR type.
Journal of autoimmunity 1990;3(5):573-7.
1990: Rothe H; Fehsel K; Kolb H
Tumour necrosis factor alpha production is upregulated in diabetes prone BB rats.
Diabetologia 1990;33(9):573-5.
1990: Kuglin B; Rjasanowski I; Bertrams J; Gries F A; Kolb H; Michaelis D
Antibodies to proinsulin and insulin as predictive markers of type 1 diabetes.
Diabetic medicine : a journal of the British Diabetic Association 1990;7(4):310-4.
1990: Zielasek J; Burkart V; Kolb H
[Interleukin-2 modifies the development of insulin-dependent diabetes of BB rats]
Immunität und Infektion 1990;18(2):55-6.
1990: Kolb H; Burkart V; Appels B; Hanenberg H; Kantwerk-Funke G; Kiesel U; Funda J; Schraermeyer U; Kolb-Bachofen V
Essential contribution of macrophages to islet cell destruction in vivo and in vitro.
Journal of autoimmunity 1990;3 Suppl 1():117-20.
1990: Zielasek J; Burkart V; Naylor P; Goldstein A; Kiesel U; Kolb H
Interleukin-2-dependent control of disease development in spontaneously diabetic BB rats.
Immunology 1990;69(2):209-14.
1990: Flechner I; Maruta K; Burkart V; Kawai K; Kolb H; Kiesel U
Effects of radical scavengers on the development of experimental diabetes.
Diabetes research (Edinburgh, Scotland) 1990;13(2):67-73.
1989: Schmidt M; Epstein S; Maruta K; Kawai K; Burkart V; Kiesel U; Kolb H
Modulation of arachidonic acid metabolism has limited effects on the development of type I diabetes in animal models.
Diabetes research (Edinburgh, Scotland) 1989;12(4):161-4.
1989: Maruta K; Treichel U; Kolb-Bachofen V; Kolb H
Prospective analysis of eosinophilia in spontaneously diabetic BB rats: correlation with islet inflammation but not with diabetes development.
Diabetes research (Edinburgh, Scotland) 1989;11(4):173-6.
1989: Appels B; Burkart V; Kantwerk-Funke G; Funda J; Kolb-Bachofen V; Kolb H
Spontaneous cytotoxicity of macrophages against pancreatic islet cells.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(11):3803-8.
1989: Kuglin B; Bertrams J; Kolb H; Gries F A
[Early diagnosis of type-1 diabetes. Limits, possibilities and outlook]
Deutsche medizinische Wochenschrift (1946) 1989;114(19):762-7.
1989: Kiesel U; Oschilewski M; Taniguchi M; Kolb H
Modulation of low-dose streptozotocin-induced diabetes in mice by administration of antibodies to I-A, I-E and I-J determinants.
Diabetologia 1989;32(3):173-6.
1989: Aring J; Schlepper-Schaefer J; Burkart V; Kolb H
Nonenzymatically glycated serum albumin: interaction with galactose-specific liver lectins.
Biochimica et biophysica acta 1989;1010(2):140-4.
1989: Hanenberg H; Kolb-Bachofen V; Kantwerk-Funke G; Kolb H
Macrophage infiltration precedes and is a prerequisite for lymphocytic insulitis in pancreatic islets of pre-diabetic BB rats.
Diabetologia 1989;32(2):126-34.
1989: Martin S; Kolb-Bachofen V; Kiesel U; Kolb H
Pathogenesis of low dose streptozotocin induced diabetes in mice: requirement for alpha 1-adrenoceptor activation and vasoactive amine release.
Diabetologia 1989;32(2):140-2.
1989: Kuglin B; Bertrams J; Linke C; Gries F A; Kolb H
Prevalence of cytoplasmatic islet cell antibodies and insulin autoantibodies is increased in subjects with genetically defined high risk for insulin-dependent diabetes mellitus.
Klinische Wochenschrift 1989;67(2):66-73.
1988: Kuglin B; Hübinger A; Gries F A; Kolb H; Bertrams J
No evidence for increased variation in first phase insulin response to intravenous glucose.
Diabetologia 1988;31(8):637-8.
1988: Martin S; Maruta K; Burkart V; Gillis S; Kolb H
IL-1 and IFN-gamma increase vascular permeability.
Immunology 1988;64(2):301-5.
1988: Kolb H; Marx-Soho Moumé C; Kiesel U
Administration of a 600 kD molecular fraction from pancreatic islets suppresses immune mediated diabetes in mice.
Journal of autoimmunity 1988;1(3):243-52.
1988: Kolb H; Dannehl K; Grüneklee D; Zielasek J; Bertrams J; Hübinger A; Gries F A
Prospective analysis of islet cell antibodies in children with type 1 (insulin-dependent) diabetes.
Diabetologia 1988;31(4):189-94.
1988: Kolb-Bachofen V; Epstein S; Kiesel U; Kolb H
Low-dose streptozocin-induced diabetes in mice. Electron microscopy reveals single-cell insulitis before diabetes onset.
Diabetes 1988;37(1):21-7.
1988: Kuglin B; Gries F A; Kolb H
Evidence of IgG autoantibodies against human proinsulin in patients with IDDM before insulin treatment.
Diabetes 1988;37(1):130-2.
1987: Kantwerk G; Cobbold S; Waldmann H; Kolb H
L3T4 and Lyt-2 T cells are both involved in the generation of low-dose streptozotocin-induced diabetes in mice.
Clinical and experimental immunology 1987;70(3):585-92.
1987: Kolb H; Oschilewski M; Oschilewski U; Schwab E; Moumé C M; Greulich B; Burkart V; Zielasek J; Kiesel U
Analysis of 22 immunomodulatory substances for efficacy in low-dose streptozotocin-induced diabetes.
Diabetes research (Edinburgh, Scotland) 1987;6(1):21-7.
1987: Mohr M; Kolb H; Kolb-Bachofen V; Schlepper-Schäfer J
Recognition of xenogeneic erythrocytes: the GalNAc/Gal-particle receptor of rat liver macrophages mediates or participates in recognition.
Biology of the cell / under the auspices of the European Cell Biology Organization 1987;60(3):217-24.
1986: Schwab E; Burkart V; Freytag G; Kiesel U; Kolb H
Inhibition of immune-mediated low-dose streptozotocin diabetes by agents which reduce vascular permeability.
Immunopharmacology 1986;12(1):17-21.
1986: Oschilewski M; Schwab E; Kiesel U; Opitz U; Stünkel K; Kolb-Bachofen V; Kolb H
Administration of silica or monoclonal antibody to Thy-1 prevents low-dose streptozotocin-induced diabetes in mice.
Immunology letters 1986;12(5-6):289-94.
1986: Kolb H; Oschilewski M; Schwab E; Greulich B; Roos P; Kiesel U
Suppression of low-dose streptozotocin-induced diabetes by immunomodulatory lectins.
Diabetes research (Edinburgh, Scotland) 1986;3(4):183-6.
1986: Kolb H; Zielasek J; Treichel U; Freytag G; Wrann M; Kiesel U
Recombinant interleukin 2 enhances spontaneous insulin-dependent diabetes in BB rats.
European journal of immunology 1986;16(2):209-12.
1986: Kiesel U; Maruta K; Treichel U; Bicker U; Kolb H
Suppression of spontaneous insulin-dependent diabetes in BB rats by administration of ciamexone.
Journal of immunopharmacology 1986;8(3):393-406.
1985: Kolb H; Oschilewski M; Schwab E; Oschilewski U; Kiesel U
Effect of cyclosporin A on low-dose streptozotocin diabetes in mice.
Diabetes research (Edinburgh, Scotland) 1985;2(4):191-3.
1985: Oschilewski U; Kiesel U; Kolb H
Administration of silica prevents diabetes in BB-rats.
Diabetes 1985;34(2):197-9.
1984: Wrede G; Kiesel U; Freytag G; Kolb H
Chronic insulitis after partial islet damage by passive insulin antibody transfer.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1984;16 Suppl 1():97-101.
1983: Flohr K; Kiesel U; Freytag G; Kolb H
Insulitis as a consequence of immune dysregulation: further evidence.
Clinical and experimental immunology 1983;53(3):605-13.
1982: Kolb H; Kiesel U; Greulich B; van der Bosch J
Lack of antidiabetic effect of (-)-epicatechin.
Lancet 1982;1(8284):1303-4.
1981: Kiesel U; Greulich B; Moumé C M; Kolb H
Induction of experimental autoimmune diabetes by low-dose streptozotocin treatment in genetically resistant mice.
Immunology letters 1981;3(4):227-30.
1981: Kiesel U; Kolb H; Freytag G
Strain dependency of the transfer of experimental immune insulitis in mice.
Clinical and experimental immunology 1981;43(2):430-3.
1981: Kolb H; Freytag G; Kiesel U; Kolb-Bachofen V
Cellular immune reactions against pancreatic islets as a consequence of graft versus host disease.
Clinical and experimental immunology 1981;43(1):121-7.
1980: Kolb H; Freytag G; Kiesel U; Kolb-Bachofen V
Spontaneous autoimmune reactions against pancreatic islets in mouse strains with generalized autoimmune disease.
Diabetologia 1980;19(3):216-21.
1980: Kiesel U; Freytag G; Biener J; Kolb H
Transfer of experimental autoimmune insulitis by spleen cells in mice.
Diabetologia 1980;19(6):516-20.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Hubert Kolb

Research Profile (preview)

Anatomy

Disorders

Living Beings

Chemicals & Drugs

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Hubert Kolb (preview)

All Publications